Financial Architects (New Jersey)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $490K | Sell |
6,052
-530
| -8% | -$43.3K | 0.07% | 209 |
|
|
2023
Q1 | $524K | Buy |
6,582
+674
| +11% | +$47.8K | 0.08% | 197 |
|
|
2022
Q4 | $400K | Hold |
5,908
| – | – | 0.07% | 235 |
|
|
2022
Q3 | $294K | Buy |
+5,908
| New | +$316K | 0.05% | 250 |
|
|
2022
Q2 | – | Sell |
-5,168
| Closed | -$287K | – | 188 |
|
|
2022
Q1 | $287K | Hold |
5,168
| – | – | 0.04% | 269 |
|
|
2021
Q4 | $289K | Hold |
5,168
| – | – | 0.04% | 274 |
|
|
2021
Q3 | $248K | Sell |
5,168
-188
| -4% | -$9.09K | 0.04% | 290 |
|
|
2021
Q2 | $224K | Buy |
+5,356
| New | +$208K | 0.03% | 314 |
|
|
2020
Q3 | – | Sell |
-5,156
| Closed | -$169K | – | 593 |
|
|
2020
Q2 | $169K | Hold |
5,156
| – | – | 0.04% | 268 |
|
|
2020
Q1 | $155K | Hold |
5,156
| – | – | 0.04% | 253 |
|
|
2019
Q4 | $149K | Hold |
5,156
| – | – | 0.03% | 276 |
|
|
2019
Q3 | $133K | Hold |
5,156
| – | – | 0.03% | 288 |
|
|
2019
Q2 | $132K | Hold |
5,156
| – | – | 0.02% | 327 |
|
|
2019
Q1 | $135K | Hold |
5,156
| – | – | 0.02% | 388 |
|
|
2018
Q4 | $119K | Hold |
5,156
| – | – | 0.02% | 366 |
|
|
2018
Q3 | $122K | Hold |
5,156
| – | – | 0.02% | 413 |
|
|
2018
Q2 | $119K | Sell |
5,156
-3,130
| -38% | -$74.4K | 0.02% | 379 |
|
|
2018
Q1 | $204K | Buy |
8,286
+800
| +11% | +$21K | 0.04% | 304 |
|
|
2017
Q4 | $201K | Buy |
7,486
+1,750
| +31% | +$44.5K | 0.03% | 321 |
|
|
2017
Q3 | $138K | Hold |
5,736
| – | – | 0.02% | 424 |
|
|
2017
Q2 | $123K | Sell |
5,736
-1,902
| -25% | -$38.4K | 0.02% | 437 |
|
|
2017
Q1 | $131K | Sell |
7,638
-4,330
| -36% | -$75.4K | 0.02% | 401 |
|
|
2016
Q4 | $215K | Sell |
11,968
-2,050
| -15% | -$37.2K | 0.05% | 243 |
|
|
2016
Q3 | $291K | Buy |
14,018
+110
| +0.8% | +$2.73K | 0.08% | 192 |
|
|
2016
Q2 | $374K | Buy |
13,908
+222
| +2% | +$6.09K | 0.11% | 161 |
|
|
2016
Q1 | $371K | Hold |
13,686
| – | – | 0.13% | 126 |
|
|
2015
Q4 | $397K | Hold |
13,686
| – | – | 0.16% | 137 |
|
|
2015
Q3 | $371K | Sell |
13,686
-630
| -4% | -$17.8K | 0.16% | 132 |
|
|
2015
Q2 | $392K | Sell |
14,316
-1,000
| -7% | -$28.1K | 0.14% | 123 |
|
|
2015
Q1 | $409K | Buy |
15,316
+6,760
| +79% | +$156K | 0.16% | 115 |
|
|
2014
Q4 | $181K | Buy |
8,556
+96
| +1% | +$2.14K | 0.08% | 180 |
|
|
2014
Q3 | $201K | Hold |
8,460
| – | – | 0.1% | 147 |
|
|
2014
Q2 | $195K | Buy |
+8,460
| New | +$187K | 0.09% | 152 |
|
|
2013
Q4 | – | Sell |
-240
| Closed | -$4K | – | 421 |
|
|
2013
Q3 | $4K | Buy |
+240
| New | +$4.04K | ﹤0.01% | 612 |
|
Other funds holding NVO
F
Financial Architects (New Jersey)'s NVO Position: Q2 2023 in Review
Financial Architects (New Jersey) reduced its Novo Nordisk (NVO) stake by 8.1% in Q2 2023, selling an estimated $43.3K and leaving 6,052 shares worth $490K. The position accounts for 0.07% of the portfolio, ranked #209.
Financial Architects (New Jersey) first reported a position in NVO in Q3 2013 and has held it in 34 quarters since. The position peaked at $524K in Q1 2023. 1,196 funds tracked by Wall St. Rank hold NVO as of Q2 2023.
- Financial Architects (New Jersey) held 6,052 shares of Novo Nordisk worth $490K as of Q2 2023.
- Financial Architects (New Jersey) sold 530 Novo Nordisk shares in Q2 2023, an estimated $43.3K.
- Novo Nordisk made up 0.07% of Financial Architects (New Jersey)'s portfolio in Q2 2023, its #209 holding.
- Financial Architects (New Jersey) first reported a position in Novo Nordisk in Q3 2013 and has held it in 34 quarters since.
- Financial Architects (New Jersey)'s Novo Nordisk position peaked at $524K in Q1 2023.
- 1,196 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.
Based on Financial Architects (New Jersey)'s 13F filing for Q2 2023, filed 10 Aug 2023.